Novo Nordisk (NVO) is up 8.1%, or $3.92 to $52.02.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Eli Lilly Stock (LLY) Falls as Rival Novo Nordisk’s Obesity Pill Gets U.S. Approval
- Novo Nordisk Wins FDA Approval for First Oral Wegovy Pill for Weight Management in the US
- Novo Nordisk rises 9.0%
- Unusually active option classes on open December 23rd
- Morning Movers: Novo Nordisk gains after Wegovy pill approved